Skip to main content
  • ENG
  • FR

Search form

Medicines for Malaria Venture

Developing antimalarials to save lives

  • Research & Development
    • MMV-supported projects
    • R&D areas of work
      • Next-generation medicines
      • Products for key populations
    • Working with regulators
    • Information for scientists
      • Malaria online course
      • Global health compound design webinars
      • Call for proposals
      • TPPs & TCPs
      • Learning resources for scientists
    • Project of the year award
    • Computational chemistry
    • R&D challenges
  • Access
    • Products & projects
    • Product availability maps
    • Areas of work
      • Supporting introduction
      • Enhancing reach
      • Informing R&D
      • Gathering market intelligence
    • Tool Kits
      • Injectable Artesunate tool kit
      • Artesunate rectal capsules tool kit
      • Seasonal Malaria Chemoprevention tool kit
    • Access challenges
  • Partnering
    • The PDP model
    • Our partner network
    • Our donors
      • Current donors
      • Past donors
    • Donate to MMV
    • Socially responsible agreements
    • Our clinical centre partners
  • Our impact
    • Milestones
    • Real life stories
    • Better medicines for children
    • Gender equity
    • Global health security
      • Malaria and COVID-19
      • Tackling antimicrobial resistance
  • About us
    • What we do
      • An overview of our work
      • Our strategic focus
      • Our history
    • People & governance
      • Staff bios
      • Staff interviews
      • Board of Directors
      • MMV North America Board
      • Expert Scientific Advisory Committee
      • Access & Product Management Advisory Committee
      • Global Safety Board
    • Work with us
      • Jobs
      • RFPs/RFIs
    • Policies
    • Diversity at MMV
    • Funding and expenditure
    • FAQs
    • Contact us
  • Malaria & medicines
    • Definitions and symptoms
    • Five species
    • Parasite lifecycle
    • Malaria facts & figures
    • Malaria treatment
    • History of antimalarials
  • Newsroom
    • News & Press Releases
    • Audio
      • Media interviews
      • Speaking of Malaria podcast
    • Films
    • Infographics
    • Interviews
    • Image slideshows
    • Publications
    • Events
  • MMV Open
    • Malaria Libre
      • About Malaria Libre
      • Participate in Malaria Libre
      • Malaria Libre data repository
    • MMVSola
      • About MMVSola
    • Pandemic Response Box
      • About the Pandemic Response Box
      • Request the Pandemic Response Box
      • Supporting information
      • Terms & conditions
    • COVID Box
      • About the COVID Box
      • Supporting information
      • COVID Box terms and conditions
    • Archived projects
      • Pathogen Box
      • Malaria Box
    • MMV Open Team
    • Contact us
  • Our 5th Call for African Proposals is now open!

  • Watch this video to learn about the MMV team!

  • Living happily, protected from malaria. Read Tenin's story.

    Photo: Toby Madden/MMV

Milestones

  • .
    150+ active partners working to defeat malaria

    Find out more

  • .
    USD1 = USD 3.5 investment impact

    Find out more

  • .
    12 compounds in clinical development

    Find out more

Home

News

ARCTIC will explore the operational feasibility of quantitative G6PD testing prior to treatment with tafenoquine or primaquine.

MMV announces the start of ARCTIC, a feasibility study of a new Plasmodium vivax malaria treatment protocol

22 Jul 2022
News story

Antimicrobials such as antimalarials are the most reported substandard and falsified medicines.

MMV echoes Fight the Fakes Alliance’s call for Global Fund Replenishment to prevent increase in falsified medicines

14 Jul 2022
News story

GSK484 raises the bar for all future preclinical candidates.

MMV awards Project of the Year 2021 to GSK for the discovery of GSK484

12 Jul 2022
News story
A photo of David Reddy standing at a lectern and speaking at the Kigali Summit

MMV commits to working with African manufacturers to enhance equitable access to antimalarials on the continent 

MMV’s Dr David Reddy makes commitment at the Kigali Summit

27 Jun 2022
News story
View all news

Defeating malaria together

  • Discover MMV's image slideshows

  • Films and animations

  • Open source research

Featured resources

  • Opinion: In support of an integrated approach to defeat malaria

    When the World Health Organization recommended widespread use of the first malaria vaccine last year, the news reinvigorated the fight against this deadly disease.

    Jun 2022
    Publication
  • Protecting Children: 10 Years of Seasonal Malaria Chemoprevention

    On the Day of the African Child, MMV reflects on what 10 years of seasonal malaria chemoprevention has meant for young children in the Sahel, and how to protect more children going forward.

    Jun 2022
    Publication
  • Culture and geography along the road to health impact

    MMV experts André-Marie Tchouatieu, Director of Access and Product Management and Maud Majeres Lugand, Associate Director of Social Research discuss the road to health impact through the lens of local culture and geography.

    Jun 2022
    Podcast

Events

  • 13
    Sep

    Malaria in Pregnancy Working Group Annual Meeting

    September 13 - 15, 2022
    Accra, Ghana
View all events
  • RSS subscribe
    Printer friendly

Follow us

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Subscribe

Previous newsletters

Contact us

  • Tel: +41 22 555 03 00

    • Message us
    • Office directions
© MMV 2022
Website by Manta Ray Media
  • Glossary
  • Disclaimer
  • Privacy
  • Sitemap